English
Home > Products > CAS NO:1644670-37-0

China CAS NO:1644670-37-0 Factory

Sticking to the principle of "Super Good quality, Satisfactory service" ,We are striving to become an excellent organization partner of you for CAS NO:1644670-37-0,Iptacopan API,Iptacopan, Our goal is always to enable clients comprehend their plans. We have been creating good endeavours to accomplish this win-win scenario and sincerely welcome you to join us.
CAS NO:1644670-37-0, We believe with our consistently excellent service you can get the best performance and cost least goods from us for a long term . We commit to offer better services and create more value to all our customers. Hope we can create a better future together.

Related Products

Hot Products

  • Fmoc-Cys(Trt)-OH

    Fmoc-Cys(Trt)-OH

    Product Name:Fmoc-Cys(Trt)-OH
    Molecular Formula:C37H31NO4S
    Molecular Weight:585.71
    CAS Registry Number:103213-32-7
  • 2-Chloro-4-pyridinecarboxylic acid

    2-Chloro-4-pyridinecarboxylic acid

    Product Name:2-Chloro-4-pyridinecarboxylic acid
    Molecular Formula:C6H4ClNO2
    Molecular Weight:157.55
    CAS Registry Number:6313-54-8
  • Cabazitaxel

    Cabazitaxel

    Product Name:Cabazitaxel
    Molecular Formula:C45H57NO14
    Molecular Weight:835.93
    CAS Registry Number:183133-96-2
  • Terbinafine Hydrochloride

    Terbinafine Hydrochloride

    Product Name:Terbinafine Hydrochloride
    Molecular Formula:C21H26ClN
    Molecular Weight;327.89
    CAS Registry Number;78628-80-5
  • 2,4-Difluoronitrobenzene

    2,4-Difluoronitrobenzene

    Product Name:2,4-Difluoronitrobenzene
    Molecular Formula:C6H3F2NO2
    Molecular Weight:159.09
    CAS Registry Number:446-35-5
  • Sodium carboxymethyl cellulose

    Sodium carboxymethyl cellulose

    Product Name:Sodium carboxymethyl cellulose
    Molecular Formula:C6H7O2(OH)2CH2COONa
    CAS Registry Number:9004-32-4
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept